Ardent Health, Inc. (NYSE:ARDT) Receives Average Rating of "Hold" from Brokerages

Key Points

• Hold is the consensus from 14 analysts (2 sell, 5 hold, 7 buy) with an average 12‑month price target of $14.25.
• The company missed the latest quarter (EPS $0.32 vs. $0.35; revenue $1.61B vs. $1.63B), set FY2026 guidance of 0.900–1.270 EPS (analysts expect 1.11), and the stock trades around $9.67 (1‑yr range $8.07–$15.48).
• Institutional investors have been accumulating shares in recent quarters, most notably Goldman Sachs, which increased its position to 767,862 shares after buying ~724,841 shares in Q1.

Ardent Health, Inc. (NYSE:ARDT - Get Free Report) has received an average rating of "Hold" from the fourteen ratings firms that are covering the stock, MarketBeat reports. Two research analysts have rated the stock with a sell recommendation, five have given a hold recommendation and seven have assigned a buy recommendation to the company. The average twelve-month price objective among brokers that have issued ratings on the stock in the last year is $14.25.

A number of research firms have issued reports on ARDT. JPMorgan Chase & Co. cut their price objective on shares of Ardent Health from $12.00 to $11.00 and set a "neutral" rating on the stock in a report on Tuesday, January 20th. Leerink Partners cut their price objective on shares of Ardent Health from $16.00 to $15.00 and set an "outperform" rating on the stock in a report on Friday, March 6th. Zacks Research raised shares of Ardent Health from a "strong sell" rating to a "hold" rating in a report on Wednesday, March 25th. Finally, Royal Bank Of Canada cut their price target on shares of Ardent Health from $14.00 to $13.00 and set an "outperform" rating on the stock in a report on Monday, March 9th.

Ardent Health Price Performance

ARDT opened at $9.67 on Wednesday. The company has a debt-to-equity ratio of 0.64, a current ratio of 1.97 and a quick ratio of 1.85. The company has a market capitalization of $1.38 billion, a price-to-earnings ratio of 10.07 and a beta of 0.57. The firm's fifty day moving average price is $9.25 and its two-hundred day moving average price is $9.92. Ardent Health has a 1 year low of $8.07 and a 1 year high of $15.48.

Ardent Health (NYSE:ARDT - Get Free Report) last posted its quarterly earnings data on Wednesday, March 4th. The company reported $0.32 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.35 by ($0.03). The firm had revenue of $1.61 billion for the quarter, compared to analysts' expectations of $1.63 billion. Ardent Health had a return on equity of 14.30% and a net margin of 2.15%.Ardent Health has set its FY 2026 guidance at 0.900-1.270 EPS. As a group, analysts anticipate that Ardent Health will post 1.11 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Ardent Health

A number of hedge funds and other institutional investors have recently made changes to their positions in ARDT. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its holdings in shares of Ardent Health by 103.8% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 14,104 shares of the company's stock worth $194,000 after buying an additional 7,182 shares during the last quarter. Goldman Sachs Group Inc. boosted its holdings in shares of Ardent Health by 1,684.9% in the 1st quarter. Goldman Sachs Group Inc. now owns 767,862 shares of the company's stock worth $10,558,000 after buying an additional 724,841 shares during the last quarter. Jane Street Group LLC boosted its holdings in shares of Ardent Health by 235.1% in the 1st quarter. Jane Street Group LLC now owns 57,468 shares of the company's stock worth $790,000 after buying an additional 40,318 shares during the last quarter. Acadian Asset Management LLC boosted its holdings in shares of Ardent Health by 574.9% in the 1st quarter. Acadian Asset Management LLC now owns 40,238 shares of the company's stock worth $550,000 after buying an additional 34,276 shares during the last quarter. Finally, Geode Capital Management LLC boosted its holdings in shares of Ardent Health by 0.6% in the 2nd quarter. Geode Capital Management LLC now owns 286,848 shares of the company's stock worth $3,918,000 after buying an additional 1,769 shares during the last quarter.

Ardent Health Company Profile

Ardent Health, listed on the New York Stock Exchange under the ticker ARDT, is a healthcare delivery company focused on acquiring, developing and managing acute care hospitals and complementary outpatient facilities across the United States. The company's integrated platform encompasses both inpatient and outpatient services, designed to provide end-to-end care solutions and address the full continuum of patient needs.

Through its network, Ardent Health operates general hospitals, emergency departments, ambulatory surgery centers, urgent care clinics, rehabilitation and post-acute care facilities.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.